scorecardresearch
Add as a preferred source on Google
Wednesday, November 5, 2025
TopicUSFDA

Topic: USFDA

How the humble hydroxychloroquine has become India’s unlikely new global strategic asset

Donald Trump has labelled hydroxychloroquine a 'game-changer' in the fight against Covid-19. Indian pharma companies have gained significantly from this.

US FDA orders removal of ranitidine drugs from market over ‘carcinogen contamination’

Ranitidine is available in India under brand names of Aciloc and Zinetac but FDA specifically names Sanofi’s Zantac.

Torrent Pharma warned by US again, this time for using bacteria-contaminated water system

In the last 11 months, USFDA has issued 23 warning letters to Indian drugmakers. For Torrent Pharma, it's the third this year.

On Camera

Pakistan can’t bomb or bargain its way out of the TTP-TLP mess

Among the many problems Pakistan is currently dealing with, the TLP and TTP offer two varying dimensions of the same one.

Kerala’s silent startup surge—work near home, smooth roads, fast internet & diaspora engagement

Once seen as a fading presence on India’s investment & startup picture, the state is slowly moving up the ladder, with policy reforms & infrastructure building.

India & Israel ink agreement to share, co-develop & co-produce advanced defence tech

Agreement signed during 17th Joint Working Group (JWG) on defence cooperation. Defence Secretary Rajesh Kumar Singh met Director General in Israeli Ministry of Defence Amir Baram Tuesday. 

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.